...Hello, everyone, and welcome to the Biovica Q4 and year-end report. And here's our forward-looking statement disclaimer. The presenter for the webcast today will be me, Anders Rylander, the CEO, followed by Anders MorTn, our CFO. Then Hector Tamburini, Head of US Operations, will present the US development; and also Henrik Winther responsible for our pharma businesses area. And the agenda we'll go through is our standard agenda. We'll start with a short introduction for the people that are not so aware with our business, then we'll move into the fourth quarter and the highlights, and Anders will follow and give a financial update. Then Hector will do the US update. Henrik will do pharma services update, and then I will summarize and we'll move into the Q&A session. And for the Q&A session, we will have our three equity researchers analyst from Pareto, from Kempen and from Redeye that we will let in to the meeting to ask questions directly. But all of you that are listening into this webcast...
